366
Views
23
CrossRef citations to date
0
Altmetric
Articles

High prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflammatory diseases and corticosteroid therapy

, , , , &
Pages 208-213 | Accepted 06 Oct 2011, Published online: 09 Mar 2012

References

  • Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, . Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004;10:1713–20.
  • Saksasithon S, Sungkanuparph S, Thanakitcharu S. Pneumocystis carinii pneumonia in patients without HIV infection. J Med Assoc Thai 2003;86:612–16.
  • Riebold D, Hennig A, Loebermann M, Schareck W, Reisinger EC. Pneumocystis pneumonia in an alcoholic patient with prolonged mechanical ventilation. Eur J Clin Microbiol Infect Dis 2005;24:294–6.
  • Sowden E, Carmichael AJ. Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention. BMC Infect Dis 2004;4:42.
  • Overgaard UM, Helweg-Larsen J. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002–2004. Scand J Infect Dis 2007;39:589–95.
  • Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995;162:233–5.
  • Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, . Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002;21:523–31.
  • Maskell NA, Waine DJ, Lindley A, Pepperell JC, Wakefield AE, Miller RF, . Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax 2003;58:594–7.
  • Gluck T, Geerdes-Fenge HF, Straub RH, Raffenberg M, Lang B, Lode H, . Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection 2000;28:227–30.
  • Lertnawapan R, Totemchokchyakarn K, Nantiruj K, Janwityanujit S. Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus. Rheumatol Int 2009;29:491–6.
  • Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H. Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000;118:712–20.
  • Chabe M, Dei-Cas E, Creusy C, Fleurisse L, Respaldiza N, Camus D, . Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and rt-PCR data demonstrate active replication. Eur J Clin Microbiol Infect Dis 2004;23:89–97.
  • Miller RF, Ambrose HE, Wakefield AE. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J Clin Microbiol 2001;39:3877–82.
  • Medrano FJ, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, . Pneumocystis jirovecii in general population. Emerg Infect Dis 2005;11:245–50.
  • Morris A, Kingsley LA, Groner G, Lebedeva IP, Beard CB, Norris KA. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004;18:793–8.
  • Helweg-Larsen J, Jensen JS, Dohn B, Benfield TL, Lundgren B. Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia – a case-control study. BMC Infect Dis 2002;2:28.
  • Mori S, Cho I, Ichiyasu H, Sugimoto M. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod Rheumatol 2008;18:240–6.
  • Savoia D, Millesimo M, Cassetta I, Forno B, Caramello P. Detection of Pneumocystis carinii by DNA amplification in human immunodeficiency virus-positive patients. Diagn Microbiol Infect Dis 1997;29:61–5.
  • Tornatore KM, Venuto RC, Logue G, Davis PJ. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure. J Med 1998; 29:159–83.
  • Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol 2010:125:S195–203.
  • Tabarsi P, Mirsaeidi M, Amiri M, Karimi S, Masjedi MR, Mansouri D. Inappropriate use of steroid and Pneumocystis jiroveci pneumonia: report of two cases. East Mediterr Health J 2008;14:1217–21.
  • Wissmann G, Morilla R, Martin-Garrido I, Friaza V, Respaldiza N, Povedano J, . Pneumocystis jirovecii colonization in patients treated with infliximab. Eur J Clin Invest 2011:41:343–8.
  • Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, . Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener’s granulomatosis. Am J Respir Crit Care Med 1995;151:795–9.
  • Mori S, Imamura F, Kiyofuji C, Ito K, Koga Y, Honda I, . Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody. Mod Rheumatol 2006;16:58–62.
  • Kadoya A, Okada J, Iikuni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996;23:1186–8.
  • Beck JM, Cushion MT. Pneumocystis workshop: 10th anniversary summary. Eukaryot Cell 2009;8:446–60.
  • Harigai M, Koike R, Miyasaka N. Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med 2007;357:1874–6.
  • Rodriguez LA, Tolosa LB, Ruigomez A, Johansson S, Wallander MA. Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol 2009;38:173–7.
  • Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, Quintero N, . Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis 2005;9:208–17.
  • Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008;197:10–17.
  • Mori S, Cho I, Sugimoto M. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis. J Rheumatol 2009;36:1600–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.